Merck CEO Rob Davis joins Bloomberg's Jonathan Ferro and Lisa Abramowicz to discuss the approval of the company's treatment for high blood pressure called Winrevair.

Utah Governor Spencer Cox Talks Meta Settlement
10:53

Lam Research CEO Tim Archer Talks AI Infrastructure Buildout
06:36

Vanguard & Altruist CEOs Talk Wealth Platform Deal, Prediction Markets
11:55